Is Tesaro (NASDAQ:TSRO) a Buy or a Sell? What Does H.C. Wainwright Think?

October 13, 2017 - By Stephen Andrade

 Is Tesaro (NASDAQ:TSRO) a Buy or a Sell? What Does H.C. Wainwright Think?

Investors sentiment increased to 1.46 in 2017 Q2. Its up 0.06, from 1.4 in 2017Q1. It improved, as 38 investors sold TESARO Inc shares while 70 reduced holdings. 73 funds opened positions while 85 raised stakes. 55.42 million shares or 0.39% more from 55.21 million shares in 2017Q1 were reported.

Teachers Retirement System Of The State Of Kentucky owns 31,052 shares or 0.05% of their US portfolio. Botty Investors Ltd holds 0.04% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 1,000 shares. Guggenheim Capital Ltd Co accumulated 40,413 shares or 0.01% of the stock. Kbc Group Nv owns 5,053 shares. Great West Life Assurance Can holds 0% or 9,620 shares in its portfolio. Blue Jay Capital Management Ltd Company has invested 6.43% of its portfolio in TESARO Inc (NASDAQ:TSRO). Trellus Mgmt Ltd invested 1.73% in TESARO Inc (NASDAQ:TSRO). Fred Alger Management has invested 0.19% in TESARO Inc (NASDAQ:TSRO). Jefferies Ltd has 11,600 shares for 0.01% of their portfolio. 7,160 were reported by Glg L P. Peak6 Invests L P reported 0.02% stake. Los Angeles Mgmt And Equity Research accumulated 0.01% or 7,081 shares. Prudential Fin Inc stated it has 1,660 shares. Balyasny Asset Limited Liability accumulated 41,700 shares or 0.02% of the stock. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 3,326 shares.

Since June 6, 2017, it had 0 buys, and 1 insider sale for $1.18 million activity.

Why Has H.C. Wainwright Given Tesaro (NASDAQ:TSRO) a $158 Price Target

The financial firm H.C. Wainwright has today has begun coverage on Tesaro (NASDAQ:TSRO) shares, with a “Buy” rating, while giving it the price target at $158.

Investors sentiment increased to 1.46 in 2017 Q2. Its up 0.06, from 1.4 in 2017Q1. It improved, as 38 investors sold TESARO Inc shares while 70 reduced holdings. 73 funds opened positions while 85 raised stakes. 55.42 million shares or 0.39% more from 55.21 million shares in 2017Q1 were reported.

Teachers Retirement System Of The State Of Kentucky owns 31,052 shares or 0.05% of their US portfolio. Botty Investors Ltd holds 0.04% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 1,000 shares. Guggenheim Capital Ltd Co accumulated 40,413 shares or 0.01% of the stock. Kbc Group Nv owns 5,053 shares. Great West Life Assurance Can holds 0% or 9,620 shares in its portfolio. Blue Jay Capital Management Ltd Company has invested 6.43% of its portfolio in TESARO Inc (NASDAQ:TSRO). Trellus Mgmt Ltd invested 1.73% in TESARO Inc (NASDAQ:TSRO). Fred Alger Management has invested 0.19% in TESARO Inc (NASDAQ:TSRO). Jefferies Ltd has 11,600 shares for 0.01% of their portfolio. 7,160 were reported by Glg L P. Peak6 Invests L P reported 0.02% stake. Los Angeles Mgmt And Equity Research accumulated 0.01% or 7,081 shares. Prudential Fin Inc stated it has 1,660 shares. Balyasny Asset Limited Liability accumulated 41,700 shares or 0.02% of the stock. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 3,326 shares.

Since June 6, 2017, it had 0 buys, and 1 insider sale for $1.18 million activity.

TESARO Inc (NASDAQ:TSRO) Ratings Coverage

Among 22 analysts covering Tesaro Inc (NASDAQ:TSRO), 12 have Buy rating, 1 Sell and 9 Hold. Therefore 55% are positive. Tesaro Inc has $23600 highest and $56 lowest target. $158’s average target is 27.31% above currents $124.11 stock price. Tesaro Inc had 56 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of TESARO Inc (NASDAQ:TSRO) earned “Strong-Buy” rating by Raymond James on Tuesday, September 1. The rating was maintained by FBR Capital with “Outperform” on Wednesday, June 29. FBR Capital maintained it with “Outperform” rating and $133 target in Friday, November 4 report. The firm has “Hold” rating by Jefferies given on Monday, September 25. The stock has “Outperform” rating by FBR Capital on Monday, October 10. The rating was initiated by Morgan Stanley with “Overweight” on Friday, January 13. The stock of TESARO Inc (NASDAQ:TSRO) has “Buy” rating given on Wednesday, July 19 by Credit Suisse. Wedbush maintained it with “Outperform” rating and $174 target in Tuesday, March 28 report. The firm has “Buy” rating given on Friday, February 5 by Lake Street. The rating was initiated by Robert W. Baird with “Outperform” on Tuesday, July 19.

About 706,533 shares traded. TESARO Inc (NASDAQ:TSRO) has risen 254.28% since October 13, 2016 and is uptrending. It has outperformed by 237.58% the S&P500.

Analysts await TESARO Inc (NASDAQ:TSRO) to report earnings on November, 2. They expect $-1.19 earnings per share, up 39.90 % or $0.79 from last year’s $-1.98 per share. After $-2.82 actual earnings per share reported by TESARO Inc for the previous quarter, Wall Street now forecasts -57.80 % EPS growth.

TESARO, Inc. is an oncology-focused biopharmaceutical company. The company has market cap of $6.66 billion. The Firm operates through the business of developing and commercializing of oncology-focused therapeutics segment. It currently has negative earnings. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

More recent TESARO Inc (NASDAQ:TSRO) news were published by: Prnewswire.com which released: “Biotech Stocks on Investors’ Radar — Tesaro, Trevena, Omeros, and Radius Health” on October 13, 2017. Also Gurufocus.com published the news titled: “Sabby Management, Llc Buys Tesaro Inc, United Therapeutics Corp, Seattle …” on September 27, 2017. Globenewswire.com‘s news article titled: “TESARO Expands Our Way Forward Program for the Ovarian Cancer Community and …” with publication date: September 28, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.